European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading

European equities traded in the US as American depositary receipts edged lower late Monday morning, declining 0.12% to 1,470.85 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion Biotech EVAX and semiconductor company Sequans Communications SQNS, which rose 3.8% and 3.5% respectively. They were followed by biotech firm BioNTech BNTX and telecommunications operator Telefonica TEF, which were up 1.4% and 1.1% respectively.

The decliners from continental Europe were led by medical device maker EDAP EDAP and biopharmaceutical company DBV Technologies DBV, which dropped 6.4% and 4.2% respectively. They were followed by furniture maker Natuzzi NTZ and internet browser company Opera OPRA, which fell 3.9% and 3% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics SLNCF and biopharmaceutical company Akari Therapeutics AKTX, which increased 5.8% and 5.4% respectively. They were followed by software firm Endava DAVA and biopharmaceutical company Adaptimmune Therapeutics ADAP, which were up 1.7% each.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana NCNA and biotech firm Autolus Therapeutics AUTL, which fell 5.1% and 3% respectively. They were followed by biopharmaceutical companies Biodexa Pharmaceuticals BDRX and TC Biopharm TTCBPW, which were down 2.6% and 1.5% respectively.